COMP360 Psilocybin for Treatment-Resistant Depression: Positive Phase 3 Efficacy Data
Psychiatric Times
JUNE 23, 2025
News Media Around the Practice Between the Lines PsychView Expert Perspectives Case-Based Psych Perspectives Clinical Case Collective Dialogues Payer-Provider Perspective Slideshows Videos Viewpoints Conferences Conference Coverage Conference Listing Publication Psychiatric Times Job Board CME/CE Partners Editorial Resources Clinical Consult Clinical Scales Interactive Tools Partner Perspectives Q&A Quizzes Series Special Reports Sponsored Subscribe Spotlight Long-Acting Injectable Therapy i
Let's personalize your content